Mirtazapine precipitated seizures: A case report

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 4, 2008, Pages 1076-1078

  Zia Ul Haq, Mohammad ^a   Prakash, Ravi ^a   Akhtar, Sayeed ^a  

^a CENTRAL INSTITUTE OF PSYCHIATRY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; MIRTAZAPINE; PHENYTOIN;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; SEIZURE; TONIC CLONIC SEIZURE;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; DRUG INTERACTIONS; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MIANSERIN; MIDDLE AGED; SEIZURES;

EID: 42949144108     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.01.017     Document Type: Letter

References (14)

1. Barry J.J. The recognition and management of mood disorders as a comorbidity of epilepsy. Epilepsia 44 s4 (2003) 30-40
2. Biswas P.N., Wilton L.V., and Shakir S.A. The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England. J Psychopharmacol 17 1 (2003) 121-124
3. De Boer T. The pharmacological profile of mirtazapine. J Clin Psychiatry 57 suppl 4 (1996) 15-25
4. Georg J., Cornelius S., Oliver P., Doris R., Gregor L., and Ulrich H. Epileptiform EEG Patterns induced by mirtazapine in both psychiatric patients and healthy volunteers. J Clin Psychopharmacol 23 4 (2003) 421-422
5. Jacobson M.P., Haneef Z., and Vendrame M. Mirtazapine induced complex partial epilepsy. Am Epilepsy Soc Abs (2007) (Abst. 1.042)
6. Millan M.J., Gobert A., Rivet J., Adhumeau-Auclair A., Cussac D., Newman-Tancredi A., et al. Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram. Eur J Neurosci 12 3 (2000) 1079-1095
7. Montgomery S.A. Safety of mirtazapine: a review. Int Clin Psychopharmacol 10 Suppl 4 (1995) 37-45
8. Montgomery S.A. Antidepressants and seizures: emphasis on newer agents and clinical implications. Int J Clin Pract 59 12 (2005) 1435-1440
9. Münchau A., Langosch J.M., Gerschlager W., Rothwell J.C., Orth M., and Trimble M.R. Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression. J Neurol Neurosurg Psychiatry 76 (2005) 527-533
10. Prueter C., and Norra C. Mood disorders and their treatment in patients with epilepsy. J Neuropsychiatry Clin Neurosci 17 1 (2005) 20-25
11. Spaans E., van den Heuvel M.W., Schnabel P.G., Peeters P.A., Chin-Kon-Sung U.G., Colbers E.P., et al. Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects. Eur J Clin Pharmacol 58 6 (2002) 423-429
12. Spyridia S., Sokolakia S., Siamoulia M., Nimatoudisa I., Iacovidesa A., and Kaprinisa G. Status epilepticus in a patient treated with olanzapine and mirtazapine. European Psychiatry 22 Supplement 1 (2007) S163
13. Westenber H.G.M. Pharmacology of antidepressants: selectivity or multiplicity?. J Clin Psychiatry 60 suppl 17 (1999) 4-8
14. Yilmaz I., Sezer Z., Kayir H., and Uzbay T.I. Mirtazapine does not affect pentylenetetrazole- and maximal electroconvulsive shock-induced seizures in mice. Epilepsy and Behavior 11 (2007) 1-5